Invesco Ltd. Sesen Bio, Inc. Transaction History

Invesco Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.38 - $0.89 $27,284 - $63,903	-71,802 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.58 - $0.86 $46 - $69	-81 Reduced 0.11%	71,802 $43,000
Q4 2021 Feb 14, 2022	SELL	$0.73 - $1.28 $19,727 - $34,590	-27,024 Reduced 27.32%	71,883 $59,000
Q3 2021 Nov 15, 2021	BUY	$0.77 - $4.91 $20,045 - $127,822	26,033 Added 35.72%	98,907 $79,000
Q2 2021 Aug 17, 2021	BUY	$2.18 - $4.66 $158,865 - $339,592	72,874 New	72,874 $337,000
Q1 2019 May 15, 2019	SELL	$0.69 - $1.47 $12,175 - $25,938	-17,645 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$0.96 - $2.04 $16,939 - $35,995	17,645 New	17,645 $25,000

Ticker SESN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,702,000
Market Cap $127M
Description
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.